Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-25

Clinical Trial Update: Remission Rate of Newly Diagnosed Type 2 Diabetes Outpatients Treated With Short-term Intensive Insulin Therapy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial reports remission rates in newly diagnosed outpatients with Type 2 diabetes after short-term intensive insulin therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Insulin (insulin)

Snippet

Sponsor: Qianfoshan Hospital | Conditions: Type2 Diabetes | Phase 4 | Status: COMPLETED